REQUEST A DEMO
Total
USD $0.00
Search more companies

Rajvi Biotech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rajvi Biotech Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rajvi Biotech Private Limited is an unlisted company, incorporated on 26/04/2007. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24233GJ2007PTC050664 and registration number is 050664. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
5, Shubham Bunglows Nr. K. K. Nagar, Ghatlodia
Ahmedabad; Gujarat; Postal Code: 380061

Contact Details: Purchase the Rajvi Biotech Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Rajvi Biotech Private Limited report to view the information.
Registered Capital:
Purchase the Rajvi Biotech Private Limited report to view the information.
Incorporation Date:
April 26, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Rajvi Biotech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
22.01%
Total operating revenue
22.31%
Operating profit (EBIT)
128.72%
EBITDA
72.9%
Net Profit (Loss) for the Period
132.14%
Total assets
11.25%
Total equity
23.23%
Operating Profit Margin (ROS)
1.38%
Net Profit Margin
1.03%
Return on Equity (ROE)
8.84%
Debt to Equity Ratio
-67.54%
Quick Ratio
-0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?